Literature DB >> 11454807

Osteoporosis in primary biliary cirrhosis revisited.

J Newton1, R Francis, M Prince, O James, M Bassendine, D Rawlings, D Jones.   

Abstract

BACKGROUND: Primary biliary cirrhosis (PBC) is increasingly being diagnosed in the earlier non-cholestatic stages of disease. Accepted wisdom has been that PBC is frequently complicated by osteoporosis. Whether this association holds true for the broader spectrum of PBC patients now recognised has not as yet been studied. AIMS: To examine the extent to which osteoporosis occurs more commonly in PBC patients than in normal individuals of the same age and sex.
DESIGN: Retrospective review of a large cohort of well characterised PBC patients. PATIENTS: A total of 272 PBC patients with definite or probable PBC followed up for a mean of 10.1 years (total follow up 2726 patient years) who had at least one bone mineral density measurement (BMD).
RESULTS: In this unselected group of PBC patients, mean Z scores (number of SDs from age and sex matched normal mean values) at the neck of femur (NOF) and lumbar spine (LS) at first BMD measurement (7 (6) years after PBC diagnosis) were -0.1 (1.4) and 0.1 (1.4), respectively. At first BMD measurement, 18 PBC patients had Z scores less than -2.0 and 85 had T scores less than -2.5. No factors predictive of osteoporosis were found in affected patients. A total of 957 BMD measurements were performed (0.35 per patient year of follow up); 220 patients had two or more measurements. No patient went on to develop de novo osteoporosis during follow up. In the 51 patients (who were clinically representative of the whole group) who received no PBC or bone related treatment during follow up, %BMD changes per year at the NOF and LS were -1.6 (3.2) and 0.1 (2.2), respectively. No variance in this "natural" rate of BMD measurement was seen in patients receiving PBC modulating agents (including prednisolone and UDCA) or osteoporosis prophylaxis/therapy. Significant improvement at the LS was seen in patients undergoing liver transplantation.
CONCLUSIONS: Osteoporosis is not a specific complication of PBC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454807      PMCID: PMC1728382          DOI: 10.1136/gut.49.2.282

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Metabolic bone disease in primary biliary cirrhosis at presentation.

Authors:  H C Mitchison; A J Malcolm; M F Bassendine; O F James
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

2.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

3.  Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy.

Authors:  A K Kehayoglou; C D Holdsworth; J E Agnew; M J Whelton; S Sherlock
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

4.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

5.  Presentation and mortality of primary biliary cirrhosis in older patients.

Authors:  J L Newton; D E Jones; J V Metcalf; J B Park; A D Burt; M F Bassendine; O F James
Journal:  Age Ageing       Date:  2000-07       Impact factor: 10.668

Review 6.  Primary biliary cirrhosis: clinical and associated autoimmune features and natural history.

Authors:  D E Jones; O F James; M F Bassendine
Journal:  Clin Liver Dis       Date:  1998-05       Impact factor: 6.126

7.  Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis.

Authors:  T Almdal; O Schaadt; J Vesterdad Jørgensen; P Lindgreen; L Ranek
Journal:  J Intern Med       Date:  1989-03       Impact factor: 8.989

8.  Bone loss and reduced osteoblast function in primary biliary cirrhosis.

Authors:  S F Hodgson; E R Dickson; H W Wahner; K A Johnson; K G Mann; B L Riggs
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

9.  Osteoporosis in chronic cholestatic liver disease.

Authors:  A J Stellon; A Davies; J Compston; R Williams
Journal:  Q J Med       Date:  1985-11

10.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

Authors:  D S Matloff; M M Kaplan; R M Neer; M J Goldberg; W Bitman; H J Wolfe
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more
  21 in total

1.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

Review 2.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

3.  Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease.

Authors:  Lu-Qin Bian; Rong-Zhen Li; Zheng-Yun Zhang; Yan-Ji Jin; Hyung-Wook Kang; Zhen-Zhu Fang; Youn-Soo Park; Yoon-Ho Choi
Journal:  J Bone Miner Metab       Date:  2013-04-12       Impact factor: 2.626

4.  Association between primary biliary cholangitis and osteoporosis: meta-analysis.

Authors:  Junyu Fan; Qian Wang; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2017-09-26       Impact factor: 2.980

5.  Is osteoporosis a peculiar association with primary biliary cirrhosis?

Authors:  Annarosa Floreani; Andrea Mega; Valentina Camozzi; Vincenzo Baldo; Mario Plebani; Patrizia Burra; Giovanni Luisetto
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

6.  Strengthening the bones in primary biliary cirrhosis.

Authors:  Paul Angulo
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

7.  Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.

Authors:  Jerzy Konstantynowicz; Dariusz M Lebensztejn; Elzbieta Skiba; Maria E Sobaniec-Lotowska; Pawel Abramowicz; Janina Piotrowska-Jastrzebska; Maciej Kaczmarski
Journal:  J Bone Miner Metab       Date:  2010-09-14       Impact factor: 2.626

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 9.  Clinical features and management of primary biliary cirrhosis.

Authors:  Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.